Teleflex Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 03/27/2024
Teleflex Inc Stock Forecast and Price Target
The average price target for Teleflex Inc's stock set by two recognized analysts recently is $265.00, which would result in a potential upside of approximately 16.68% if it reached this mark. The estimation is based on a high estimate of $285.00 and a low estimate of $211.00. If you're not interested in TFX stock, you may be interested in its competitors.
16.68% Upside
Teleflex Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Teleflex Inc's Price has gone down from $271.76 to $0.00 – a 100.00% drop. For the next year, analysts predict that Fair Value will reach $437.57 – an increase of 100.00%. Over the next seven years, experts believe that Teleflex Inc's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$239.50 | Buy/Sell | $284.47 | 16.91% |
STE Stock Forecast | STERIS | Outperform |
13
|
$233.84 | Buy/Sell | $238.33 | 4.77% |
ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
PEN Stock Forecast | Penumbra | Outperform |
9
|
$241.62 | Buy/Sell | $258.62 | 19.40% |
GMED Stock Forecast | Globus Medical | Outperform |
16
|
$55.10 | Buy/Sell | $64.58 | 12.52% |
Teleflex Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Teleflex Inc's Revenue has grown by 17.24%, rising from $2.54B to $2.97B. For the next year, analysts predict that Revenue will reach $3.28B – an increase of 10.19%. Over the next seven years, experts believe that Teleflex Inc's Revenue will grow at a rate of 42.30%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MMSI Stock Forecast | Merit Medical Systems | Outperform |
14
|
$74.61 | Buy/Sell | $89.25 | 19.29% |
GKOS Stock Forecast | Glaukos | Outperform |
7
|
$86.86 | Buy/Sell | $87.33 | 22.04% |
HAE Stock Forecast | Haemonetics | Outperform |
16
|
$78.36 | Buy/Sell | $70.17 | 38.46% |
Teleflex Inc Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Teleflex Inc's Dividend per Share has fallen from $1.36 to $1.36 – a 0.00% decrease. According to 1 analysts, Teleflex Inc's Dividend per Share will fall by 0.00% in the next year, reaching $1.36. Looking ahead to seven years, experts forecast that Dividend per Share will grow by 45.59%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NARI Stock Forecast | Inari Medical | Outperform |
14
|
$42.49 | Buy/Sell | $82.67 | 75.34% |
ICUI Stock Forecast | ICU Medical | Outperform |
16
|
$103.51 | Buy/Sell | $153.50 | 31.87% |
NUVA Stock Forecast | NuVasive | - |
14
|
$4.86 | Buy/Sell | $73.81 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ATRC Stock Forecast | AtriCure | Outperform |
8
|
$36.92 | Buy/Sell | $55.00 | 55.74% |
LMAT Stock Forecast | LeMaitre Vascular | Outperform |
18
|
$64.78 | Buy/Sell | $59.86 | 8.06% |
IRMD Stock Forecast | IRadimed | Buy |
16
|
$43.21 | Buy/Sell | $60.00 | 38.86% |
Teleflex Inc EBITDA Forecast for 2023 - 2025 - 2030
Teleflex Inc's EBITDA has seen growth In the last three years, going from $657.25M to $759.59M – a gain of 15.57% In the next year, analysts believe that EBITDA will reach $1.08B – an increase of 41.88%. For the next seven years, the forecast is forEBITDA to grow by 93.19%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LUNG Stock Forecast | Pulmonx | Buy |
4
|
$8.71 | Buy/Sell | $15.33 | 95.18% |
ATRI Stock Forecast | Atrion | - |
18
|
$352.20 | Buy/Sell | $946.00 | -100.00% |
OFIX Stock Forecast | Orthofix Medical | Hold |
10
|
$14.30 | Buy/Sell | $18.00 | 4.90% |
Teleflex Inc EBIT Forecast for 2023 - 2025 - 2030
In the last three years, EBIT for Teleflex Inc has grown by 20.34%, going from $430.00M to $517.47M. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $989.26M – an increase of 91.17%. Over the next seven years, experts anticipate that EBIT growth for Teleflex Inc will be 127.36%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MON Stock Forecast | Misonix | - |
7
|
$26.54 | Buy/Sell | $28.00 | -100.00% |
LYRA Stock Forecast | Lyra Therapeutics | Buy |
4
|
$5.66 | Buy/Sell | $11.80 | 112.01% |
ANGO Stock Forecast | AngioDynamics | Outperform |
8
|
$5.47 | Buy/Sell | $16.33 | 155.94% |
Teleflex Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Teleflex Inc's EPS has gone down from $10.67 to $0.00 – a 100.00% drop. For the next year, analysts predict that EPS will reach $17.18 – an increase of 100.00%. Over the next seven years, experts believe that Teleflex Inc's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
APEN Stock Forecast | Apollo Endosurgery | - |
10
|
$10.00 | Buy/Sell | $0.00 | -100.00% |
SGHT Stock Forecast | Sight Sciences | Hold |
5
|
$4.47 | Buy/Sell | $3.88 | 17.45% |
TELA Stock Forecast | TELA Bio | Buy |
6
|
$5.52 | Buy/Sell | $15.20 | 171.74% |